Stock VTL VGI HEALTH TECHNOLOGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials VGI Health Technology Limited

Equities

VTL

AU0000152597

Biotechnology & Medical Research

End-of-day quote National Stock Exchange of Australia
Other stock markets
 06:00:00 2023-06-28 pm EDT 		5-day change 1st Jan Change
0.02 AUD -33.33% Intraday chart for VGI Health Technology Limited -.--% -.--%
Feb. 08 VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
2023 VGI Health Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI

Valuation

Fiscal Period: June 2021 2022 2023
Capitalization 1 27.65 4.147 2.765
Enterprise Value (EV) 1 27.63 5.91 5.042
P/E ratio -7.08 x -0.53 x -1.82 x
Yield - - -
Capitalization / Revenue - 305,404,639 x 112,395,528 x
EV / Revenue - 435,205,817 x 204,957,276 x
EV / EBITDA - - -
EV / FCF -11,167,216 x -1,419,925 x 33,514,906 x
FCF Yield -0% -0% 0%
Price to Book 3.31 x 5.63 x -4.76 x
Nbr of stocks (in thousands) 138,247 138,247 138,247
Reference price 2 0.2000 0.0300 0.0200
Announcement Date 9/7/21 8/10/22 9/6/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023
Net sales - - - 0.0136 0.0246
EBITDA - - - - -
EBIT 1 -0.5814 -1.418 -3.244 -1.541 -1.204
Operating Margin - - - -11,349.04% -4,892.53%
Earnings before Tax (EBT) 1 2.75 -1.418 -3.904 -1.663 -1.522
Net income 1 2.75 -1.418 -3.904 -7.873 -1.522
Net margin - - - -57,977.61% -6,186.86%
EPS 2 0.0393 -0.0199 -0.0282 -0.0570 -0.0110
Free Cash Flow - 0.3221 -2.474 -4.162 0.1504
FCF margin - - - -30,649.93% 611.54%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 2/23/20 5/26/21 9/7/21 8/10/22 9/6/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023
Net Debt 1 0.23 2.5 - 1.76 2.28
Net Cash position 1 - - 0.02 - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - 0.32 -2.47 -4.16 0.15
ROE (net income / shareholders' equity) - -54.5% -56.6% -36.5% -1,946%
ROA (Net income/ Total Assets) - -17.9% -21% -14.6% -21.4%
Assets 1 - 7.935 18.62 53.81 7.122
Book Value Per Share 2 -0 0.0500 0.0600 0.0100 -0
Cash Flow per Share 2 0 0 0 0 0
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 2/23/20 5/26/21 9/7/21 8/10/22 9/6/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VGI HEALTH TECHNOLOGY LIMITED Stock VGI Health Technology Limited
-.--% 1.81M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.63% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.62% 96.29B
ARGENX SE Stock argenx SE
+1.48% 22.18B
BIONTECH SE Stock BioNTech SE
-16.67% 21.2B
GENMAB A/S Stock Genmab A/S
-9.58% 18.31B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.74% 17.38B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.36B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.41% 13.97B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.57% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VTL Stock
  4. Financials VGI Health Technology Limited